Hemoadsorption with CytoSorb

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2018 Nov 18

PMID 30446798

Citations 56

Authors

Elettra C Poli

Thomas Rimmele

Antoine G Schneider

Affiliations

Soon will be listed here.

Citing Articles

CytoSorb Hemadsorption in Cardiogenic Shock: A Real-World Analysis of Hemodynamics, Organ Function, and Clinical Outcomes During Mechanical Circulatory Support.

Kreutz J, Harbaum L, Barutcu C, Rehman A, Patsalis N, Mihali K Biomedicines. 2025; 13(2).

PMID: 40002736 PMC: 11853450. DOI: 10.3390/biomedicines13020324.

To Hemoadsorb or Not to Hemoadsorb-Do We Have the Answer Yet? An Updated Meta-Analysis on the Use of CytoSorb in Sepsis and Septic Shock.

Orban C, Bratu A, Agapie M, Borjog T, Jafal M, Sima R Biomedicines. 2025; 13(1).

PMID: 39857764 PMC: 11762373. DOI: 10.3390/biomedicines13010180.

Kidney REPLACEment therapies in patients with acute kidney injury and RHABDOmyolysis (ReplaceRhabdo): a pilot trial.

Weidhase L, Borrmann A, Willenberg A, Mende M, Scharf-Janssen C, Petros S BMC Nephrol. 2025; 26(1):23.

PMID: 39810111 PMC: 11731544. DOI: 10.1186/s12882-025-03945-3.

Hemadsorption with CytoSorb®: focus on the latest experiences in cardiac surgery patients.

Spatola L, Granata A, DAmico M, Oddo G, Gambaro A J Artif Organs. 2024; .

PMID: 39708149 DOI: 10.1007/s10047-024-01485-5.

Analysis of Trends and Influencing Factors of Cytokine-Adsorbing Therapies: A Nationwide Ecological Study in Japan.

Ono S, Shimizu K Cureus. 2024; 16(11):e73489.

PMID: 39677163 PMC: 11638017. DOI: 10.7759/cureus.73489.

References

Friesecke S, Trager K, Schittek G, Molnar Z, Bach F, Kogelmann K . International registry on the use of the CytoSorb® adsorber in ICU patients : Study protocol and preliminary results. Med Klin Intensivmed Notfmed. 2017; 114(8):699-707. DOI: 10.1007/s00063-017-0342-5. View

Schadler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N . The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS One. 2017; 12(10):e0187015. PMC: 5662220. DOI: 10.1371/journal.pone.0187015. View

Kogelmann K, Jarczak D, Scheller M, Druner M . Hemoadsorption by CytoSorb in septic patients: a case series. Crit Care. 2017; 21(1):74. PMC: 5366999. DOI: 10.1186/s13054-017-1662-9. View

Malard B, Lambert C, Kellum J . In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018; 6(1):12. PMC: 5935601. DOI: 10.1186/s40635-018-0177-2. View

Kellum J, Song M, Venkataraman R . Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med. 2004; 32(3):801-5. DOI: 10.1097/01.ccm.0000114997.39857.69. View

Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer R . Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017; 43(3):304-377. DOI: 10.1007/s00134-017-4683-6. View

Nemeth E, Kovacs E, Racz K, Soltesz A, Szigeti S, Kiss N . Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation-an observational study. Clin Transplant. 2018; 32(4):e13211. DOI: 10.1111/ctr.13211. View

Bernardi M, Rinoesl H, Dragosits K, Ristl R, Hoffelner F, Opfermann P . Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care. 2016; 20:96. PMC: 4826492. DOI: 10.1186/s13054-016-1270-0. View

Reiter K, Bordoni V, Dallolio G, Ricatti M, Soli M, Ruperti S . In vitro removal of therapeutic drugs with a novel adsorbent system. Blood Purif. 2002; 20(4):380-8. DOI: 10.1159/000063108. View

10.

Gruda M, Ruggeberg K, OSullivan P, Guliashvili T, Scheirer A, Golobish T . Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS One. 2018; 13(1):e0191676. PMC: 5784931. DOI: 10.1371/journal.pone.0191676. View

11.

Gemelli C, Cuoghi A, Magnani S, Atti M, Ricci D, Siniscalchi A . Removal of Bilirubin with a New Adsorbent System: In Vitro Kinetics. Blood Purif. 2018; 47(1-3):10-15. DOI: 10.1159/000492378. View

12.

Trager K, Skrabal C, Fischer G, Datzmann T, Schroeder J, Fritzler D . Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series. Int J Artif Organs. 2017; 40(5):240-249. PMC: 6159853. DOI: 10.5301/ijao.5000583. View

13.

Friesecke S, Stecher S, Gross S, Felix S, Nierhaus A . Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J Artif Organs. 2017; 20(3):252-259. DOI: 10.1007/s10047-017-0967-4. View

14.

Trager K, Fritzler D, Fischer G, Schroder J, Skrabal C, Liebold A . Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs. 2016; 39(3):141-6. DOI: 10.5301/ijao.5000492. View

15.

Peng Z, Carter M, Kellum J . Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008; 36(5):1573-7. PMC: 3547590. DOI: 10.1097/CCM.0b013e318170b9a7. View